Currently, there is a lack of exploration of the relationship between URG methylation and the prognosis of SARC patients, and the utility of DNA methylation analysis as a predictive biomarker for immunotherapy response in sarcomas is also unclear, which is one of the purposes of this study. This evidence concerns the gene EGF and sarcoma.